JP2024503723A5 - - Google Patents

Info

Publication number
JP2024503723A5
JP2024503723A5 JP2023543239A JP2023543239A JP2024503723A5 JP 2024503723 A5 JP2024503723 A5 JP 2024503723A5 JP 2023543239 A JP2023543239 A JP 2023543239A JP 2023543239 A JP2023543239 A JP 2023543239A JP 2024503723 A5 JP2024503723 A5 JP 2024503723A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
adenosine derivative
derivative according
composition according
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023543239A
Other languages
English (en)
Japanese (ja)
Other versions
JP7843289B2 (ja
JP2024503723A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/013660 external-priority patent/WO2022159872A1/en
Publication of JP2024503723A publication Critical patent/JP2024503723A/ja
Publication of JP2024503723A5 publication Critical patent/JP2024503723A5/ja
Application granted granted Critical
Publication of JP7843289B2 publication Critical patent/JP7843289B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023543239A 2021-01-25 2022-01-25 アデノシン誘導体及びそれを含む医薬組成物 Active JP7843289B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163141450P 2021-01-25 2021-01-25
US63/141,450 2021-01-25
PCT/US2022/013660 WO2022159872A1 (en) 2021-01-25 2022-01-25 Adenosine derivative and pharmaceutical composition comprising the same

Publications (3)

Publication Number Publication Date
JP2024503723A JP2024503723A (ja) 2024-01-26
JP2024503723A5 true JP2024503723A5 (cg-RX-API-DMAC7.html) 2025-01-15
JP7843289B2 JP7843289B2 (ja) 2026-04-09

Family

ID=82494279

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023543239A Active JP7843289B2 (ja) 2021-01-25 2022-01-25 アデノシン誘導体及びそれを含む医薬組成物

Country Status (11)

Country Link
US (2) US11793827B2 (cg-RX-API-DMAC7.html)
EP (1) EP4281081A4 (cg-RX-API-DMAC7.html)
JP (1) JP7843289B2 (cg-RX-API-DMAC7.html)
KR (1) KR20230132476A (cg-RX-API-DMAC7.html)
CN (1) CN116710465A (cg-RX-API-DMAC7.html)
AU (1) AU2022210781A1 (cg-RX-API-DMAC7.html)
CA (1) CA3202049A1 (cg-RX-API-DMAC7.html)
IL (1) IL304366A (cg-RX-API-DMAC7.html)
MX (1) MX2023008004A (cg-RX-API-DMAC7.html)
WO (1) WO2022159872A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA202408803B (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL289925B2 (en) 2019-07-27 2026-03-01 Brii Biosciences Inc A derivative of adenosine and a pharmaceutical preparation containing it
AU2022211056A1 (en) 2021-01-25 2023-07-20 Brii Biosciences, Inc. Combination therapy for hiv with adenosine derivative and capsid inhibitors
KR20230132476A (ko) 2021-01-25 2023-09-15 브리 바이오사이언시스, 인크. 아데노신 유도체 및 이를 포함하는 약제학적 조성물
EP4658663A2 (en) * 2023-01-30 2025-12-10 Merck Sharp & Dohme LLC Prodrugs of 4'-substituted nucleoside reverse transcriptase inhibitors

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3407191A (en) * 1966-08-29 1968-10-22 Lilly Co Eli Adamantoate esters of nucleosides
US5880154A (en) 1994-02-01 1999-03-09 The Board Of Regents Of The University Of Nebraska Polymeric adamantane analogues
EP1667694B1 (en) 2003-09-05 2010-04-28 Anadys Pharmaceuticals, Inc. Tlr7 ligands for the treatment of hepatitis c
CA2502109C (en) 2004-03-24 2010-02-23 Yamasa Corporation 4'-c-substituted-2-haloadenosine derivative
EP1915053A2 (en) 2005-08-12 2008-04-30 Merck & Co., Inc. Novel 2'-c-methyl and 4'-c-methyl nucleoside derivatives
EP2040712B1 (en) 2006-07-18 2011-03-02 Anadys Pharmaceuticals, Inc. Carbonate and carbamate prodrugs of thiazolo [4,5-d] pyrimidines
WO2011058582A1 (en) 2009-11-16 2011-05-19 Orchid Research Laboratories Ltd. Histone deacetylase inhibitors for the treatment of fungal infections
WO2015143712A1 (en) * 2014-03-28 2015-10-01 Merck Sharp & Dohme Corp. 4'-substituted nucleoside reverse transcriptase inhibitors
WO2015187596A2 (en) 2014-06-02 2015-12-10 Regeneron Pharmaceuticals, Inc. Biologically active molecule conjugates, reagents and methods of manufacture, and therapeutic uses
JP6768796B2 (ja) * 2015-09-23 2020-10-14 メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. 4’−置換ヌクレオシド逆転写酵素阻害剤及びその調製
US20180030080A1 (en) * 2016-07-28 2018-02-01 Alexandre Vasilievich Ivachtchenko Phosphoramidate nucleoside prodrug for treating viral diseases and cancer, processes for their preparation and their use
US10266558B2 (en) * 2016-10-07 2019-04-23 Alexandre Vasilievich Ivachtchenko Macroheterocyclic nucleoside derivatives and their analogues, production and use thereof
US11337964B2 (en) 2017-02-28 2022-05-24 Kangpu Biopharmaceuticals, Ltd. Isoindoline derivative, pharmaceutical composition and use thereof
RU2659388C1 (ru) * 2017-02-28 2018-07-02 Васильевич Иващенко Александр Нуклеотиды, включающие N-[(S)-1-циклобутоксикарбонил]фосфорамидатный фрагмент, их аналоги и их применение
US20190185508A1 (en) * 2017-12-15 2019-06-20 Merck Sharp & Dohme Corp. Deuterated nucleoside reverse transcriptase inhibitors
WO2019171285A1 (en) * 2018-03-07 2019-09-12 Glaxosmithkline Intellectual Property (No.2) Limited Compounds useful in hiv therapy
CN109053803A (zh) 2018-07-04 2018-12-21 米文君 一类新的化合物及其用途
MA53280A (fr) * 2018-08-09 2021-11-17 Glaxosmithkline Ip No 2 Ltd Composés utiles dans la thérapie du vih
US20210323993A1 (en) * 2018-08-30 2021-10-21 Glaxosmithkline Intellectual Property (No. 2) Limited Compounds Useful in HIV Therapy
PH12021500034A1 (en) * 2019-03-06 2022-06-06 Glaxosmithkline Ip No 2 Ltd Compounds useful in hiv therapy
IL289925B2 (en) 2019-07-27 2026-03-01 Brii Biosciences Inc A derivative of adenosine and a pharmaceutical preparation containing it
WO2021038509A1 (en) 2019-08-28 2021-03-04 Glaxosmithkline Intellectual Property (No.2) Limited 4'-ethynyl-2'-deoxyadenosine derivatives and their use in hiv therapy
MX2022002897A (es) 2019-09-11 2022-05-16 Scripps Research Inst Profarmacos antivirales y formulaciones de los mismos.
AU2022211056A1 (en) 2021-01-25 2023-07-20 Brii Biosciences, Inc. Combination therapy for hiv with adenosine derivative and capsid inhibitors
KR20230132476A (ko) * 2021-01-25 2023-09-15 브리 바이오사이언시스, 인크. 아데노신 유도체 및 이를 포함하는 약제학적 조성물

Similar Documents

Publication Publication Date Title
JP2022541667A5 (cg-RX-API-DMAC7.html)
JP7719769B2 (ja) 抗ウイルスプロドラッグ及びその医薬組成物
JP5027885B2 (ja) 水難溶性カンプトテシン誘導体のサブミクロンナノ粒子及びその製造方法
JP6445591B2 (ja) シロリムス及びその誘導体の複合体、それらの調製方法ならびにそれらを含有する医薬組成物
JP2002510329A (ja) 親油性化合物用の自己乳化性処方
JP2007500229A5 (cg-RX-API-DMAC7.html)
PT96289B (pt) Processamento para a preparacao de composicoes farmaceuticas para o trtamento de infeccoes virais
JP2021521222A (ja) 6,8−ビス−ベンジルチオ−オクタン酸を使用して前立腺癌を治療するための治療方法および組成物
JP2006070032A (ja) 抗血管形成薬剤組成物
US20220054445A1 (en) Therapeutic methods and compositions for treating cancer using 6,8-bis-benzylthio-octanoic acid and an autophagy inhibitor
RU2358730C2 (ru) Производное эпотилона для лечения гепатомы и других раковых заболеваний
EP4157290A1 (en) Compositions, their uses in therapy and methods thereof
JP2022521119A5 (cg-RX-API-DMAC7.html)
JP2009504746A (ja) 第Xa因子インヒビターのシクロデキストリン包接複合体
CN104080449A (zh) 4,9-二羟基-萘并[2,3-b]呋喃脂肪酸酯衍生物的纳米颗粒水悬液的制备方法
CA3121929A1 (en) Therapeutic methods and compositions for treating cancer using 6,8-bis-benzylthio-octanoic acid and an autophagy inhibitor
JP4090133B2 (ja) 抗マラリア剤
RU2488398C2 (ru) Фармацевтическая комбинация опиоида и простагландинового соединения
CN105163732A (zh) 用于治疗眼科疾病和病症的方法
JPH10503178A (ja) Hiv感染のための組合わせ療法
WO2014015153A2 (en) Compositions and methods for treating ewing's sarcoma and other disorders related to ews-fli1
JP2013529686A5 (cg-RX-API-DMAC7.html)
RU2022104985A (ru) Аденозиновое производное и фармацевтическая композиция, содержащая его
EP0310259A2 (en) Eperisone as a hypotensive agent
US20170165231A1 (en) Treating ewing's sarcoma and ews-fli1 related disorders